CYTK
Cytokinetics, Incorporated · Healthcare
Director B Lynne Parshall sold $1.6M of Cytokinetics, Incorporated
Sold$1,599,326
$52.79Price
30,296Shares
−75%Stake
What CYTK did after the filing
- The stock from Fri, Sep 2 open, $54.27
- −11.3%
- S&P 500, same days
- −8.0%
Measured over 30 trading days, to the Oct 17 close.
Traded Thu, Sep 1. Filed Thu, Sep 1, 7:17 PM ET, after the close. Returns use the Sep 2 open and the Oct 17 close. Not investment advice.